Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JPMorgan Chase Q2 EPS $2.76 Misses $2.91 Estimate

JPMorgan Chase Q2 EPS $2.76 Misses $2.91 Estimate

– Reuters

byBenzinga Newsdesk

July 14, 2022

1 minute read

– Reuters

Boeing Receives Order For Six More MAZ-8s From Virgin Australia As Demand Remains Strong

By Shivani Kumaresan

November 24, 10:32 AM

Airline operator Virgin Australia has increased its pipeline of new Boeing Co (NYSE: BA) MAX family aircraft, with six more MAX-8s scheduled for delivery in the sec

Piper Sandler Maintains Overweight on JPMorgan Chase, Lowers Price Target to $158

By Benzinga Newsdesk

July 1, 6:51 AM

Piper Sandler analyst Jeffery Harte maintains JPMorgan Chase (NYSE:JPM) with a Overweight and lowers the price target from $170 to $158.

JPM

Why Is HCA Healthcare Stock Trading Lower On Friday?

By Vandana Singh

April 26, 11:34 AM

HCA Healthcare's first-quarter results, surpassing revenue and EPS expectations. CEO Sam Hazen emphasizes sustained momentum and volume growth.

HCA

Citigroup Maintains Neutral on Pactiv Evergreen, Lowers Price Target to $10

By Benzinga Newsdesk

March 8, 7:19 AM

Citigroup analyst Anthony Pettinari maintains Pactiv Evergreen (NASDAQ:PTVE) with a Neutral and lowers the price target from $12 to $10.

PTVE

JPMorgan Chase Q2 EPS $2.76 Misses $2.91 Estimate

Related Posts

Boeing Receives Order For Six More MAZ-8s From Virgin Australia As Demand Remains Strong

Piper Sandler Maintains Overweight on JPMorgan Chase, Lowers Price Target to $158

Why Is HCA Healthcare Stock Trading Lower On Friday?

Citigroup Maintains Neutral on Pactiv Evergreen, Lowers Price Target to $10